The FDA has approved Medtronic Minimed's 780G automated insulin delivery system with the Guardian 4 sensor.
can be worn for 7 days, rather than 3 days, as with the older system, and the glucose target level can be set as low as 100 mg/dL.MiniMed 670G system, which tended to frequently boot users out of automated mode, with the 780G, users spent an average of 95% of the time in the automated “SmartGuard" mode.
, overall, patients who used the 780G spent 75% of the time in ideal glucose range and 1.8% of the time below that range. Overnight, the figures were 82% and 1.5%, respectively. With the glucose target set at 100 mg/dL and active insulin time set to 2 hours, patients spent 78.8% of time in range without increased hyperglycemia.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA Still Struggles to Inspect Foreign Drug Manufacturers After COVID DelaysA series of deaths linked to bacteria-tainted eyedrops produced overseas has raised alarm over a lag in FDA inspections.
Consulte Mais informação »
Foghorn Therapeutics stock slides 21% after FDA puts partial clinical hold on cancer drug trialFoghorn Therapeutics Inc.’s stock slid 21% in premarket trade Monday, after the biotech said the Food and Drug Administration has placed a partial hold on a...
Consulte Mais informação »
Kamala Harris says wrong name for FDA in interview about mifepristoneHarris mistakenly said the Federal Drug Administration approved the abortion pill mifepristone more than two decades ago — but such an agency doesn’t exist.
Consulte Mais informação »
President of planned parenthood reacts to SCOTUS abortion pill rulingThe Supreme Court ruled for mifepristone, the most commonly used abortion pill, to stay on the market until the Court of Appeals decides whether the FDA’s approval of the drug over 20 years ago was valid. The president of Planned Parenthood, Alexis McGill Johnson, reminds us to not forget the patients and providers on the other side of this ruling and explains how the fight for reproductive rights is far from over. She joined American Voices to discuss.
Consulte Mais informação »
Canadian firms to release GMP-compliant MDMA capsules for clinical trials worldwideMDMA made in safe and controlled environments is now being used for clinical trials under FDA approval. Can the once recreational drug treat what pharma cannot?
Consulte Mais informação »
After the high court decision, what's next for mifepristone?The Supreme Court has ruled to allow mifepristone to be prescribed as a lower court continues an appeal on its FDA approval. But what's to come?
Consulte Mais informação »